Young adults, health care use and psychosis
年轻人、医疗保健使用和精神病
基本信息
- 批准号:9028539
- 负责人:
- 金额:$ 45.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-05-01 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAdmission activityAffectAgeAge of OnsetCaringClinicClinicalComplementComplexDataDiagnosisDiffuseDiffusionDiffusion of InnovationDisability InsuranceDoseEarly DiagnosisEarly InterventionEarly identificationEmergency department visitEmployee StrikesEvidence based treatmentFamilyFemaleHealth PlanningHealthcareHealthcare SystemsHome environmentHospitalsIndividualInpatientsInterviewKnowledgeLeadMedicalMental HealthMental disordersModelingOutcomePharmaceutical PreparationsPopulationProviderPsychotic DisordersQualifyingRecoveryRelapseResourcesSamplingSchizophreniaSchoolsServicesStructureSuicide attemptSystemTimeTreatment EfficacyVulnerable PopulationsWorkbaseclinical practicecohortcommunity based serviceevidence basefirst episode psychosisimprovedimproved outcomeinnovationinterestmaleprogramstrendyoung adult
项目摘要
PROJECT SUMMARY
Young adulthood is the most common period of onset for schizophrenia. Early identification and receipt of comprehensive treatment during first episode psychosis (FEP) leads to improvements in recovery, outcome and relapse rates. Yet, US studies consistently find an average duration of untreated psychosis greater than one year. One critical barrier to identification and treatment for this vulnerable group may be the fragmented US health care system. Young adults typically have few resources and few paths to qualify for public programs that aid individuals in navigating the complex array of medical treatments and other services potentially available for individuals with SMI. Recent improvements in the evidence-base related to treatment for FEP and how best to deliver these treatments have the potential to lead to earlier detection and improved outcomes for this vulnerable population. Yet, it is not clear these changes in the evidence-base have diffused into clinical practice. Individuals with emerging mental health disorders may reap meaningful benefits from these changes, including shorter duration of untreated psychosis, more appropriate types and dose of medications, treatment by more appropriately qualified providers, support services and treatments for general medical conditions. In this study, by examining trends in outcomes among young adults of different ages, we aim to: Aim 1: Examine whether and how inpatient and emergency department treatment for young adults with psychosis has changed over time, and explore determinants of any changes; Aim 2: Examine whether and how re-admissions for hospital-based treatments for psychosis has changed over time, and explore determinants of any changes; Aim 3: Examine whether and how the rate of emergency department visits for likely suicide attempts among young adults with a diagnosis of psychosis has changed over time, and explore determinants of any changes. In addition, we aim to: Aim 4 (exploratory): Describe state and plan innovation in public program benefits for young adults with FEP. For aims 1-3, we will compare trends in outcomes among individuals of different ages and cohorts in various states using national and state data on hospital admissions and emergency department use. For aim 4 we will conduct qualitative interviews with representatives from states, providers and health plans to document innovations related to identification and treatment of vulnerable individuals with FEP and other emerging SMI. Psychosis strikes at a time when individuals are in school, entering the workforce, starting families, or making other choices with lifetime consequences. Recent scientific work offers opportunities to improve care for this vulnerable population, possibly resulting in lifetime increases in functioning. This work will be relevant to directors and other stakeholders interested in better understanding the benefits of providing more comprehensive and innovative services to individuals with emerging SMI.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan H Busch其他文献
Access to treatment before and after Medicare coverage of opioid treatment programs
在医疗保险承保阿片类药物治疗计划之前和之后获得治疗
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Ruijie Liu;Tamara Beetham;Helen Newton;Susan H Busch - 通讯作者:
Susan H Busch
Two steps forward, one step back? Implications of the Supreme Court's health reform ruling for individuals with mental illness.
前进两步,后退一步?
- DOI:
10.1001/jamapsychiatry.2013.25 - 发表时间:
2013 - 期刊:
- 影响因子:25.8
- 作者:
Ezra Golberstein;Susan H Busch - 通讯作者:
Susan H Busch
Declines in psychiatric care in inpatient settings in Israel mirror global trend
- DOI:
10.1186/2045-4015-2-30 - 发表时间:
2013-08-15 - 期刊:
- 影响因子:2.200
- 作者:
Susan H Busch;Dominic Hodgkin - 通讯作者:
Dominic Hodgkin
Susan H Busch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susan H Busch', 18)}}的其他基金
Substance use disorder treatment centers and facility ownership changes
药物滥用障碍治疗中心和设施所有权变更
- 批准号:
10680862 - 财政年份:2023
- 资助金额:
$ 45.26万 - 项目类别:
Alternative payment models and alcohol use disorder treatment and consequences
替代支付模式和酒精使用障碍治疗及后果
- 批准号:
10464490 - 财政年份:2022
- 资助金额:
$ 45.26万 - 项目类别:
Alternative payment models and alcohol use disorder treatment and consequences
替代支付模式和酒精使用障碍治疗及后果
- 批准号:
10642757 - 财政年份:2022
- 资助金额:
$ 45.26万 - 项目类别:
Expanding Treatment of Opioid Dependence Among the Privately Insured
扩大私人受保人对阿片类药物依赖的治疗
- 批准号:
8117251 - 财政年份:2009
- 资助金额:
$ 45.26万 - 项目类别:
Expanding Treatment of Opioid Dependence Among the Privately Insured
扩大私人受保人对阿片类药物依赖的治疗
- 批准号:
7924579 - 财政年份:2009
- 资助金额:
$ 45.26万 - 项目类别:
Expanding Treatment of Opioid Dependence Among the Privately Insured
扩大私人受保人对阿片类药物依赖的治疗
- 批准号:
8287681 - 财政年份:2009
- 资助金额:
$ 45.26万 - 项目类别:














{{item.name}}会员




